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Abstract
Modeling disease progression in healthcare administrative databases is compli-
cated by the fact that patients are observed only at irregular intervals when
they seek healthcare services. In a longitudinal cohort of 76,888 patients with
chronic obstructive pulmonary disease (COPD), we used a continuous-time hid-
den Markov model with a generalized linear model to model healthcare utilization
events. We found that the fitted model provides interpretable results suitable for
summarization and hypothesis generation.
1 Introduction
Chronic diseases typically progress slowly over many years. For example, patients with chronic
obstructive pulmonary disease (COPD) may progress from mild to very severe stages of the disease
over the span of more than a decade [8]. By advancing our ability to model such disease progression,
we can improve early detection, proper management and accurate prognosis of diseases. Crucial
to modeling disease progression is making use of the vast amounts of individual patient data in
the form of longitudinal health records, such as electronic health records (EHRs) and healthcare
administrative databases. However, processes like chronic disease progression are not observed
directly or explicitly recorded in these databases, but are rather underlying processes that generate
the observations. As a result, inferential methods are needed to identify how patients move through
stages of a disease.
Adding to the complexity of modeling disease progression is the fact that patient data is only
recorded when they receive services from the health system, resulting in very irregularly-spaced
observations that will differ in granularity between patients and across time within a patient. Dis-
ease trajectories, in terms of rates of progression and profiles of healthcare use, will also vary widely
across patients, further creating challenges in synthesizing progression. Furthermore, for large seg-
ments of patient trajectories records may be very sparse due to infrequent visit or in many cases
incomplete (e.g., censored data or care provided outside the health system).
To deal with the heterogeneous, sparse, non-equidistant, and incomplete longitudinal observations
in a cohort COPD patients we apply our recently developed continuous-time hidden Markov model
(CTHMM) under a generalized linear modeling framework [2]. Such multi-state models can capture
patient status over time as a discrete-time realization of a continuous-time Markov process, while
accommodating irregular spacing of observations [9]. Previous research in disease progression mod-
eling has typically made use of known disease status or transition rates [1, 11, 10] rather than model-
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Figure 1: Healthcare service by time with most probable hidden state for nine sample patients.
ing the latent process as a stochastic process. By using a hidden Markov model (HMM), we assume
that the Markov property is imposed on the unobserved sequence governing the observations. In this
study, we fit a CTHMM to a large cohort of COPD patients to evaluate how well the model could
generate hypotheses about the evolution of the illness and how to improve its management.
2 Methods
2.1 Data
A cohort of COPD patients was selected from an open, dynamic cohort beginning in 1998 (with
yearly re-sampling), capturing a 25% random sample drawn from the registered with the provin-
cial health insurance agency (Régie de l’assurance maladie du Québec) in the census metropolitan
area of Montreal. Patients were followed until they died or moved out of the region. The admin-
istrative records include outpatient diagnoses and procedures submitted through billing claims, and
procedures and diagnoses from hospital records.
Using established case-definitions based on diagnostic codes [6], we enrolled 76,888 COPD patients
as of their incident event occurring after a minimum of two years of time at risk (ICD-9 491x, 492x,
496x; ICD-10 J41-J44) with follow-up until December 2014. When patients were observed by the
health system, their discrete state was only indirectly measured through a proxy of types of health
services received, specifically, outpatient visits with a general practitioner (GP), outpatient visits
with a specialist (Spec) (coded as respirologist or internist), visits to an emergency department (ED),
and all-cause hospitalizations (Hosp). Health service uses were not considered if they occurred prior
to the incident COPD event.
2.2 Model description
To model disease progression within the COPD cohort, we used a continuous-time hidden Markov
model (CTHMM). The observable data in this CTHMM was the healthcare utilization event, which
was one of four mutually exclusive events (GP, Spec, ED, Hosp). If events occured on the same day,
then we used the most severe event, where Hosp was the most severe, follwed by ED, Spec, and GP.
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Figure 2: Probability of state membership by time for each of three starting states.
Given that there was an observed event, the probability of each of the four observables was deter-
mined by a multinomial model, using GP as the reference event. The multinomial model had a set
of three binary covariates, coding one of four previous observed events, along with an intercept.
Because the observed healthcare utilization events were irregularly-spaced in time, we modeled the
transitions between hidden states in continuous time. Because patients may have extended periods
without any healthcare visits, we allowed for transitions between states even if there were no ob-
served healthcare utilization events. The transition rate between states was specified by a rate matrix
Q, which was fit as part of the model. The hidden states were interpreted as belonging to states of
disease severity, by computing the probability of healthcare utilization events with known levels of
severity.
2.3 Model fit
Our model required us to fit three sets of parameters. pi specified the probability of starting in each
state, Q specified the transition matrix between each state, and β specified the probability of each
observable for each state.
For each state, there was a set of parameters β that specified the multinomial model of the four
healthcare utilization outcomes (GP, specialist, ED, hospital). Each state’s multinomial model was
specified as a set of three logistic regression models of the probability of specialist, ED, or hospital
visit versus the probability of a GP visit. Each logistic regression model had four parameters: an
intercept, and the previously observed healthcare utilization visit specified as three binary variables
(using one-hot encoding). With four parameters within each of three logistic regression models
within each of three states, we had 36 β parameters.
The transition rate between states was specified by the 3 × 3 (each row and column corresponding
to a state) rate matrix Q. IfXt is the state membership at time t, then Qij = lim∆t→0
P (Xt+∆t|Xt)
∆t
where i 6= j. The diagonal entries of Q are computed so that the rows of Q sum to zero. Since only
the non-diagonal entries need to be fit, there were six Q parameters in our model. We scaled ∆t to
be expressed in years.
To fit our model, we used expectation-maximization (EM) [7], an iterative algorithm in which previ-
ous parameter values are used to compute new values. EM equired us to specify starting values for
the model parameters. For pi, we specified equal probability of starting in any state, the β parameters
were randomly drawn from a normal distribution with a mean of 0 and a standard deviation of 1, and
the Q parameters were drawn from a uniform distribution between 0 and 1.
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Table 1: Probability of each healthcare utilization event, given current state, and last observed health-
care utilization event. The rows stratify the last observed event, while the columns stratify the prob-
ability of each new event, by state. GP = general practition visit, ED = emergency department visit,
Hosp = hospitalization, Spec = specialist vist.
State 1 State 2 State 3
GP ED Hosp Spec GP ED Hosp Spec GP ED Hosp Spec
GP 0.89 0.07 0.02 0.01 0.53 0.09 0.04 0.34 0.33 0.40 0.18 0.09
ED 0.50 0.32 0.17 0.01 0.30 0.32 0.2 0.18 0.11 0.57 0.26 0.06
Hosp 0.71 0.15 0.12 0.02 0.44 0.16 0.11 0.29 0.20 0.48 0.17 0.15
Spec 0.78 0.05 0.10 0.07 0.55 0.07 0.04 0.35 0.08 0.19 0.07 0.65
At each iteration of EM, we used the forward-backward algorithm [3, 4], along with the current
parameter values for pi, β, and Q, to compute, for each consecutive pair of observations within
each patient, the probability of starting and ending in each state pair. For each consecutive pair of
observations, we computed a 3×3matrix of probabilities that summed to 1. We used these matrices
to also compute the marginal probability of state membership at all observed times for all patients.
We computed a new value for pi using the mean probability of state membership at the first observed
time point across all patients, and computed new values for β by fitting a multinomial model for
each state, weighting each observation by the probability of state membership at that time. Finally,
we computed new values for Q by using a nested EM procedure [5, 12]. We stopped the algorithm
when the difference in norms between the previous and new parameter values was below 0.05.
3 Results
Table 1 describes the β coefficients of a 3-state model (a 4-state model resulted in a less meaningful
"transient" state to which the probability of transitioning was persistently minimal, i.e. < 0.10).
The β coefficients can be compared at the autoregressive term of GP visits since it is the most
frequent health service. State 1 mainly represents a well-controlled state with high probability of
GP visits (0.89), state 2 represents a mix of GP visits (0.53) and specialist visits (0.34), while state
3 represents a more severe state where ED visits (0.40) and hospitalizations (0.18) are more likely
than in the other states. The β coefficients distributions are mostly similar when compared at other
autoregressive terms. However, at the specialist visits autoregressive term in the more "severe"
state 3, the most probable event is specialist visits (0.65), with a lower probability of acute care,
suggesting differences in how disease severity progresses for patients consulting a specialist.
After 5 years, patients are more likely to remain in state 1 (0.74) or transition to it from states 2
(0.57) or 3 (0.48). While 5-year transitions to states 2 and 3 are less frequent (ranging from 0.13 to
0.16), patients have a higher probability of remaining in state 3 after 5 years (0.35) than remaining
in state 2 (0.26), suggesting a less favourable rate of recovery from the more severe state.
4 Discussion
Using a continuous-time hidden Markov model, we used healthcare utilization within a cohort of
COPD patients as a proxy for unobserved, latent, disease progression. We found that the model
provided interpretable results, allowing us to generate hypotheses about how healthcare utilization
evolves at different stages of disease progression. The model allowed us to learn dynamic changes
in underlying disease state from heterogeneous, sparse and incomplete observations. The discrete
states suggest increasing levels of severity based on a progression away from mostly primary care,
to more specialist care, and finally more acute care.
By modeling complex longitudinal observations into latent disease states, we have created opportu-
nities for future research in understanding COPD. The CTHMM can include time-varying covariates
such age, comorbidities, prescribed drugs, or socioeconomic status to identify important predictors
of progression towards greater severity. Such models can improve prognoses by matching patients
to typical trajectories of a sub-population. Also, decision makers can identify health service profiles
that are predictive of slower disease progression.
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